A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids

References

• Benson DM, Jr., Bakan CE, Mishra A, et al. (2010). The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood 116:2286–94.
   PubMed Web of Science ®Google Scholar
• Bremer C, Tung CH, Weissleder R. (2001). In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743–8.
   PubMed Web of Science ®Google Scholar
• Cabral H, Matsumoto Y, Mizuno K, et al. (2011). Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 6:815–23.
   PubMed Web of Science ®Google Scholar
• Castanotto D, Rossi JJ. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457:426–33.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang CC, Jin L, Zhang XD. (2016). Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol 27:409–16.
   PubMed Web of Science ®Google Scholar
• Clark CA, Gupta HB, Sareddy G, et al. (2016). Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma. Cancer Res 76:6964–74.
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH, et al. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067–70.
   PubMed Web of Science ®Google Scholar
• Dong P, Xiong Y, Yue J, et al. (2018). Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion. Front Oncol 8:386.
   PubMed Web of Science ®Google Scholar
• Dosio F, Arpicco S, Stella B, Fattal E. (2016). Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv Drug Deliv Rev 97:204–36.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–74.
   PubMed Web of Science ®Google Scholar
• Gato-Cañas M, Zuazo M, Arasanz H, et al. (2017). PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity. Cell Rep 20:1818–29.
   PubMed Web of Science ®Google Scholar
• Günther M, Lipka J, Malek A, et al. (2011). Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Eur J Pharm Biopharm 77:438–49.
   PubMed Web of Science ®Google Scholar
• Han M, Huang-Fu M-Y, Guo W-W, et al. (2017). MMP-2-sensitive HA end-conjugated poly(amidoamine) dendrimers via click reaction to enhance drug penetration into solid tumor. ACS Appl Mater Interfaces 9:42459–70.
   PubMed Web of Science ®Google Scholar
• Jiang G, Park K, Kim J, et al. (2008). Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 89:635–42.
   PubMed Web of Science ®Google Scholar
• Ke W, Zha Z, Mukerabigwi JF, et al. (2017). Matrix metalloproteinase-responsive multifunctional peptide-linked amphiphilic block copolymers for intelligent systemic anticancer drug delivery. Bioconjug Chem 28:2190–8.
   PubMed Web of Science ®Google Scholar
• Khansarizadeh M, Mokhtarzadeh A, Rashedinia M, et al. (2016). Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis. Hum Exp Toxicol 35:377–87.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Cho HJ, Park D, et al. (2011). Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid. Mol Ther 19:355–61.
   PubMed Web of Science ®Google Scholar
• Li J, Chen L, Xiong Y, et al. (2017). Knockdown of PD-L1 in human gastric cancer cells inhibits tumor progression and improves the cytotoxic sensitivity to CIK therapy. Cell Physiol Biochem 41:907–20.
   PubMedGoogle Scholar
• Liu B, Cao W, Qiao G, et al. (2019). Effects of gold nanoprism-assisted human PD-L1–siRNA on both gene down-regulation and photothermal therapy on lung cancer. Acta Biomater 99:307–19.
   PubMed Web of Science ®Google Scholar
• Liu L, Gou M, Yi T, et al. (2014). Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer. Oncol Rep 31:1623–8.
   PubMed Web of Science ®Google Scholar
• Liu R, Hu C, Yang Y, et al. (2019). Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 9:410–20.
   PubMed Web of Science ®Google Scholar
• Luo Z, Dai Y, Gao H. (2019). Development and application of hyaluronic acid in tumor targeting drug delivery. Acta Pharm Sin B 9:1099–112.
   PubMed Web of Science ®Google Scholar
• Mansour AM, Drevs J, Esser N, et al. (2003). A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2. Cancer Res 63:4062–6.
   PubMed Web of Science ®Google Scholar
• Olson ES, Jiang T, Aguilera TA, et al. (2010). Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci U S A 107:4311–6.
   PubMed Web of Science ®Google Scholar
• Patel S, Turner PR, Stubberfield C, et al. (2002). Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer. Int J Cancer 97:416–24.
   PubMed Web of Science ®Google Scholar
• Ruan S, He Q, Gao H. (2015). Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. Nanoscale 7:9487–96.
   PubMed Web of Science ®Google Scholar
• Schalper KA, Carvajal-Hausdorf D, McLaughlin J, et al. (2017). Differential expression and significance of PD-L1, IDO-1, and B7-H4 in human lung cancer. Clin Cancer Res 23:370–8.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. (2012). NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671–5.
   PubMed Web of Science ®Google Scholar
• Shao XR, Wei XQ, Song X, et al. (2015). Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells. Cell Prolif 48:465–74.
   PubMed Web of Science ®Google Scholar
• Suresh S, Chen B, Zhu J, et al. (2020). eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer. Nat Cancer 1:533–45.
   PubMedGoogle Scholar
• Teo PY, Yang C, Whilding LM, et al. (2015). Ovarian cancer immunotherapy using PD-L1–siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing. Adv Healthc Mater 4:1180–9.
   PubMed Web of Science ®Google Scholar
• Tu Y, Zhu L. (2016). Matrix metalloproteinase-sensitive nanocarriers. In: Torchilin V, ed. Smart pharmaceutical nanocarriers. London, UK: Imperial College Press. 83–116.
   Google Scholar
• Turk BE, Huang LL, Piro ET, Cantley LC. (2001). Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotechnol 19:661–7.
   PubMed Web of Science ®Google Scholar
• van de Wetering P, Schuurmans-Nieuwenbroek NM, Hennink WE, Storm G. (1999). Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. J Gene Med 1:156–65.
   PubMed Web of Science ®Google Scholar
• Varkouhi AK, Scholte M, Storm G, Haisma HJ. (2011). Endosomal escape pathways for delivery of biologicals. J Control Release 151:220–8.
   PubMed Web of Science ®Google Scholar
• Whelan J. (2005). First clinical data on RNAi. Drug Discov Today 10:1014–5.
   PubMed Web of Science ®Google Scholar
• Yu W, He X, Yang Z, et al. (2019). Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis. Biomaterials 217:119309.
   PubMed Web of Science ®Google Scholar
• Yu W, Liu R, Zhou Y, Gao H. (2020). Size-tunable strategies for a tumor targeted drug delivery system. ACS Cent Sci 6:100–16.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chan HF, Leong KW. (2013). Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 65:104–20.
   PubMed Web of Science ®Google Scholar
• Zou W, Wolchok JD, Chen L. (2016). PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med 8:328rv4.
   PubMed Web of Science ®Google Scholar